Beatriz Martín-Antonio

Featured publications

• Extracellular NK histones promote immune cell anti-tumor activity by inducing cell clusters through binding to CD138 receptor

  Authors: Martín-Antonio B; Suñe G; Najjar A; Perez-Amill L; Antonaña-Vildosola A; Castella M; León S; Velasco-De Andrés M; Lozano F; Lozano E; Bueno C; Estanyol JM; Munõz-Pinedo C; Robinson SN; Urbano-Ispizua A.

  Reference: Journal For Immunotherapy Of Cancer 2019.

• Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions

  Authors: Castella M, Boronat A, Martín-Ibáñez R, Rodríguez V, Suñé G, Caballero M, Marzal B, Pérez-Amill L, Martín-Antonio B, Castaño J, Bueno C, Balagué O, González-Navarro EA, Serra-Pages C, Engel P, Vilella R, Benitez-Ribas D, Ortiz-Maldonado V, Cid J, Tabera J, Canals JM, Lozano M, Baumann T, Vilarrodona A, Trias E, Campo E, Menendez P, Urbano-Ispizua Á, Yagüe J, Pérez-Galán P, Rives S, Delgado J, Juan M .

  Reference: Molecular Therapy-Methods & Clinical Development 2019.

• CAR-T cell therapy, a door is open to find innumerable possibilities of treatments for cancer patients.

  Authors: Perez-Amill L, Marzal B, Urbano-Ispizua A, Juan M, Martín-Antonio B .

  Reference: Turkish Journal Of Hematology 2018.

• Immunotherapy: A Novel Era of Promising Treatments for Multiple Myeloma

  Authors: Castella M; de Larrea C; Martín-Antonio B.

  Reference: International Journal Of Molecular Sciences 2018.

• Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.

  Authors: Suárez-Lledó M, Martínez-Cibrián N, Gutiérrez-García G, Dimova-Svetoslavova V, Marcos MA, Martín-Antonio B, Martínez-Trillos A, Villamor N, Rosiñol L, Martínez C, Fernández-Avilés F, García-Vidal C, Urbano-Ispizua Á, Rovira M .

  Reference: Biology Of Blood And Marrow Transplantation 2018.

• Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

  Authors: Lozano E, Díaz T, Mena MP, Suñe G, Calvo X, Calderón M, Pérez-Amill L, Rodríguez V, Pérez-Galán P, Roué G, Cibeira MT, Rosiñol L, Isola I, Rodríguez-Lobato LG, Martin-Antonio B, Bladé J, Fernández de Larrea C .

  Reference: Journal Of Immunology 2018.

• Natural killer cells: Angels and devils for immunotherapy

  Authors: Martín-Antonio B; Suñe G; Perez-Amill L; Castella M; Urbano-Ispizua A.

  Reference: International Journal Of Molecular Sciences 2017.

• Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking

  Authors: Martin-Antonio, B.; Najjar, A.; Robinson, S. N.; Chew, C.; Li, S.; Yvon, E.; Thomas, M. W.; Mc Niece, I.; Orlowski, R.; Munoz-Pinedo, C.; Bueno, C.; Menendez, P.; Fernandez de Larrea, C.; Urbano-Ispizua, A.; Shpall, E. J.; Shah, N.;.

  Reference: Cell Death And Differentiation 2015.

• Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors

  Authors: Baez, A; Martin-Antonio, B; Piruat, JI; Prats, C; Alvarez-Laderas, I; Barbado, MV; Carmona, M; Urbano-Ispizua, A; Perez-Simon, JA.

  Reference: Haematologica 2014.